Large-Cap Biotechs Poised For Second-Half Rally, RBC Says By: Benzinga via Benzinga July 09, 2015 at 09:21 AM EDT RBC Capital Markets Analyst Michael Yee said in a new research note that the recent 5 to 6 percent pullback in large-cap biotech will ... Read More >> Related Stocks: Amgen Biogen Idec Celgene Corp Gilead Sciences